Embecta earnings were $58.2M for the trailing 12 months ending Dec 31, 2024, with 4.2% growth year over year. The latest EMBC earnings report on Dec 31, 2024 announced Q4 2024 earnings of $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, EMBC reported annual earnings of $78.3M, with 11.2% growth.
EMBC past earnings growth
How has EMBC's earnings growth performed historically?
On EMBC's earnings call on Invalid Date, Embecta (NASDAQ: EMBC) reported Q4 2024 earnings per share (EPS) of $0.00, up 100% year over year. Total EMBC earnings for the quarter were $0.00. In the same quarter last year, Embecta's earnings per share (EPS) was $0.35.
As of the last Embecta earnings report, Embecta is currently profitable. Embecta's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $58.20 million, a 5.24% increase year over year.
What was EMBC's earnings growth in the past year?
As of Embecta's earnings date in Invalid Date, Embecta's earnings has grown 4.17% year over year. This is 28.86 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 33.03%. EMBC earnings in the past year totalled $58.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.